Clinical Trial Update: Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study evaluating boosted Lopinavir/ritonavir dosing in infants and young children co-infected with HIV and tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Tuberculosis

Drugs mentioned

• Kaletra (Lopinavir/ritonavir) (lopinavir/ritonavir)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Acquired Immunodeficiency Syndrome, Tuberculosis | Phase 4 | Status: COMPLETED